The UCF College of Medicine has hired a 麻豆精品 S渨orld-class scientist 麻豆精品 S from Ohio State University for its first endowed chair in Cardiovascular Sciences.
麻豆精品 S淗e is amazing, 麻豆精品 S said Dr. Pappachan Kolattukudy, director of the Burnett School of聽 Biomedical Sciences, who is himself a researcher in cardiovascular disease. 麻豆精品 S淗e is a world-class scientist who is acknowledged by everyone in the profession. He is also a world-class scholar. It is a significant achievement for us to get someone like this. 麻豆精品 S
Dr. Parthasarathy is a recognized expert in lipids who is credited with the co-discovery of a major cardiovascular concept 麻豆精品 S the fact that oxidized LDL cholesterol blocks arterial vessels in the heart. His areas of interest include arteriosclerosis, cardiovascular nutrition and heart failure. Dr. Parthasarathy has a breadth of research experience, including studies on endometriosis, aspirin therapy and heart disease related to diabetes.
His work is extensively funded by the National Institute of Health (NIH), and he has received聽more than聽23,000 citations of his research findings. He belongs to an elite group — consisting of the top fraction of 1 percent — of the most highly cited authors worldwide in his field, as designated in Highly Cited Authors by ISI, the world authority in聽 the analysis of impact of research.
Dr. Kolattukudy said Florida Hospital, a College of Medicine partner, is 麻豆精品 S渢hrilled 麻豆精品 S with Dr. Parthasarathy 麻豆精品 S檚 appointment because of the opportunity to work together on translational research and clinical trials for heart disease treatments. 麻豆精品 S淥ur new endowed chair really gives us the opportunity to have bench to bedside research, 麻豆精品 S he said.
In addition to research, Dr. Parthasarathy will also serve as a mentor to fellow Burnett School faculty. 麻豆精品 S淢y major goals are to continue my vigorous scientific research and provide mentoring, motivation and direction to junior scientists, 麻豆精品 S he said.
Dr. Parthasarathy begins work at the Burnett School on Nov. 1.